Better adherence to antihypertensive agents and risk reduction of chronic heart failure

Journal of Internal Medicine

Volumn 266, Issue 2, 2009, Pages 207-218

  Perreault, S ^a   Dragomir, A ^a   White, M ^a   Lalonde, L ^a   Blais, L ^a   Berard A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adherence to treatment; Antihypertensive drugs; Chronic heart failure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SCORING SYSTEM; SOCIAL SUPPORT; CANADA; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; PUBLIC HEALTH; STATISTICAL MODEL; STATISTICS;

AGED; ANTIHYPERTENSIVE AGENTS; CANADA; CASE-CONTROL STUDIES; CORONARY DISEASE; DATABASES, FACTUAL; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PUBLIC HEALTH; RISK REDUCTION BEHAVIOR;

EID: 67650503176     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02084.x     Document Type: Article

References (48)

1. Fondation des maladies du Coeur du Canada. (Fondation des maladies du Coeur du Canada). Le fardeau croissant des maladies cardiovasculaires et des accidents vasculaires cérébraux au Canada, 2003. Report No.: 1-89624-32-4.
2. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006 113 : e85 151.
3. Mark DB, Van de Werf FJ, Simes RJ et al. Cardiovascular disease on a global scale: defining the path forward for research and practice. Eur Heart J 2007 28 : 2678 84.
4. Jessup M, Brozena S. Heart failure. NEJM 2003 348 : 2007 17.
5. McDonald K. Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance. Int J Cardiol 2008 125 : 197 202.
6. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993 88 : 107 15.
7. Bourassa MG, Gurné O, Bangdiwala SI et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1992 22 (Suppl. A 14A 9A.
8. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998 97 : 282 9.
9. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet 2003 362 : 1527 35.
10. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure drugs: results of prospectively designed overviews of randomised trials. Lancet 2000 355 : 1955 64.
11. Wolf-Maier K, Cooper RS, Kramer H et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004 43 : 10 7.
12. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997 10 (10 Pt 1 1097 102.
13. Tu K, Chen Z, Lipscombe LL for the Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population based study. CMAJ 2008 178 : 1429 35.
14. Leenen FHH, Dumais J, McInnis NH et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008 178 : 1441 9.
15. Mohan S, Campbell NRC. Hypertension management in Canada: good news, but important challenges remain. CMAJ 2008 178 : 1458 60.
16. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004 19 : 357 62.
17. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L and on the behalf of the ANBP2 Management Committee. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). MJA 2006 185 : 487 9.
18. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries, and Cause of Death, 9th edn. Geneva, Switzerland : World Health Organization, 1977 Publication no PHS 80-1260).
19. Canada: Supply and Services. Canadian Classification of Diagnostic, Therapeutic, and Surgical Procedures, 2nd edn. Ottawa, ON, Canada : Statistics Canada Health Division, 1986.
20. Régie de l'assurance maladie. Liste des médicaments Québec, 15th edn. Canada : Régie de l'assurance maladie, 2003.
21. Régie de l'assurance maladie du Québec, Québec Canada. Rapport annuel de gestion 2003-2004. Principales variables selon la catégorie de personnes assurées. Studies and Statistics, 2005, Government of Quebec, Available at: http://www.ramq.gouv.qc.ca (accessed on 20 September 2006).
22. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995 48 : 999 1009.
23. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004 57 : 131 41.
24. Tamblyn R, Reid T, Mayo N, McLeod P, Churchill-Smith M. Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment. J Clin Epidemiol 2000 53 : 183 94.
25. Monfared A, Rahme E, LeLorier J. Accuracy of ICD-9 diagnosis code '410' to identify episodes of hospitalizations for acute myocardial infarction in RAMQ. First Canadian Therapeutics Congress 2004. Halifax, Canada, 2004.
26. Lee WY, Capra AM, Jensvold NG, Gurwitz JH, Go AS for the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) Study. Gender and risk of adverse outcomes in heart failure. Am J Cardiol 2004 94 : 1147 52.
27. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure : the Framingham study. NEJM 1971 285 : 1441 6.
28. Lubin J, Gail M. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984 40 : 63 75.
29. Peterson AM, Nau DP, Cramer JA et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007 10 : 3 12. (Pubitemid 46161090)
30. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005 11 : 449 57.
31. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006 40 : 1280 8.
32. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353 : 487 97.
33. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992 45 : 197 203.
34. Essebag V, Platt R, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 2005 5 : 5 11.
35. Greene WH. Econometric Analysis, 3rd edn. Upper Saddle River, NJ : Prentice-Hall, 1997, p. 552.
36. Belsley DA, Kuy E, Welsch RE. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New-York : John Wiley & Sons, 1981.
37. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000 5 : 167 73.
38. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Heart Study. J Am Coll Cardiol 1993 22 : 6A 13A. (Pubitemid 23285789) (Pubitemid 23285789)
39. Kannel WB, Bélanger AJ. Epidemiology of heart failure. Am Heart J 1991 121 : 951 7.
40. Padeletti M, Jelic S, LeJemtel TH. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 2008 125 : 209 15.
41. Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiology terminology. Am J Epidemiol 1999 149 : 981 3.
42. Simpson SH, Eurich DT, Majumdar SR et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006 333 : 15 21.
43. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007 297 : 177 86.
44. Daskalopoulo SS, Delaney JAC, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J 2008 29 : 2083 91.
45. Khan NA, McAlister FA, Rabkin SW et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol 2006 22 : 583 93.
46. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: an analysis of 354 randomized trials. BMJ 2003 326 : 1427.
47. Choo PW, Rand CS, Inui TS et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999 37 : 846 57.
48. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006 15 : 565 74.